Inhibition of 5-lipoxygenase activity by the natural anti-inflammatory compound aethiopinone

Inflammation Research

Volumn 50, Issue 2, 2001, Pages 96-101

  Benrezzouk, R ^a   Terencio, M C ^a   Ferrandiz, M L ^a   Hernandez Perez, M ^b   Rabanal, R ^b   Alcaraz, M J ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

5 lipoxygenase; Aethiopinone; Air pouch; Ear oedema

Indexed keywords

AETHIOPINONE; ANTIINFLAMMATORY AGENT; ARACHIDONATE 5 LIPOXYGENASE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG ISOLATION; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MEDIATOR RELEASE; PERITONEUM MACROPHAGE; PLANT ROOT; STRUCTURE ACTIVITY RELATION; TISSUE INJURY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; EAR; EDEMA; HUMANS; INFLAMMATION; ISOENZYMES; LEUKOTRIENE B4; LIPOXYGENASE INHIBITORS; MACROPHAGES, PERITONEAL; MEMBRANE PROTEINS; MICE; NAPHTHOQUINONES; NEUTROPHILS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHOLIPASES A; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 0035093585     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050730     Document Type: Article

References (35)

1. Analgesic, anti-inflammatory, antipyretic and haematological effects of aethiopinone, an o-naphtoquinone diterpenoid from Salvia aethiopis roots and two hemisynthetic derivatives
2. Expression of the protein product of the prostaglandin synthase-2/TIS 10 gene in mitogen stimulated Swiss 3T3 cells
3. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases
4. The role of leukotrienes in inflammation
5. Leukotrienes and lipoxins: Structures, biosynthesis and biological effects
6. Translocation of 5-lipoxygenase to the membrane in human leukocytes challenged with ionophore A23187
7. Role of the 5-lipoxygenase-activating protein (FLAP) in murine acute inflammatory responses
8. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis
9. Designing therapeutically effective 5-lipoxygenase inhibitors
10. Determinants of 5-lipoxygenase nuclear localization using green fluorescent protein/5-lipoxygenase fusion proteins
11. 4 pathway to inflammation control
12. An orthoquinone isolated from Salvia aethiopis
13. A study of the novel anti-inflammatory agent florifenine. Topical anti-inflammatory activity and influence on arachidonic acid metabolism and neutrophil functions
14. Selectivity of neutrophil 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids
15. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: Biochemical assessment in vitro and ex vivo
16. 2 associated with rabbit polymorphonuclear leukocyte granules
17. 2 activity in the zymosan rat air pouch model of inflammation
18. 2 from the human monocytic cell line U937
19. 2 by diacylglycerol
20. 1 macrophage-like cell line
21. Characterization of nitric oxide synthases in non-adrenergic non-cholinergic nerve containing tissue from the rat anococcygeus muscle
22. Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents
23. The formation of a structure with the features of synovial lining by subcutaneous injection of air: An in vivo tissue culture system
24. Neutrophils, host defense, and inflammation: A double-edged sword
25. Inhibition of 5-lipoxygenase blocks IL-1 beta-induced vascular adhesion molecule-1 gene expression in human endothelial cells
26. Platelets, neutrophils, and vasoconstriction after arterial injury by angioplasty in pigs: Effects of MK-886, a leukotriene biosynthesis inhibitor
27. Systemic neutrophil intrinsic 5-lipoxygenase activity and CD18 receptor expression linked to reperfusion injury
28. Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene
29. Intracolonic administration of zileuton, a selective 5-lipoxygenase inhibitor, accelerates healing in a rat model of chronic colitis
30. A pilot study of zileuton, a novel selective 5-lipoxygenase inhibitor, in patients with systemic lupus erythematosus
31. Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis
32. Antileukotriene drugs in the management of asthma
33. New approaches to anti-inflammatory therapy for asthma
34. Treatment of asthma with drugs modifying the leukotriene pathway
35. 5-Lipoxygenase